Deepwater Asset Management LLC Makes New Investment in Astera Labs, Inc. $ALAB

Deepwater Asset Management LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 4th quarter, Holdings Channel reports. The fund bought 51,428 shares of the company’s stock, valued at approximately $8,556,000. Astera Labs accounts for approximately 2.5% of Deepwater Asset Management LLC’s portfolio, making the stock its 19th largest holding.

Several other institutional investors also recently made changes to their positions in the stock. Los Angeles Capital Management LLC boosted its position in shares of Astera Labs by 108.7% during the 4th quarter. Los Angeles Capital Management LLC now owns 4,614 shares of the company’s stock worth $782,000 after purchasing an additional 2,403 shares in the last quarter. Havemeyer Place LP purchased a new stake in shares of Astera Labs during the 4th quarter worth $1,386,000. Vestcor Inc boosted its position in shares of Astera Labs by 244.0% during the 4th quarter. Vestcor Inc now owns 3,784 shares of the company’s stock worth $630,000 after purchasing an additional 2,684 shares in the last quarter. Pinebridge Investments LLC purchased a new stake in shares of Astera Labs during the 4th quarter worth $682,000. Finally, Fjarde AP Fonden Fourth Swedish National Pension Fund purchased a new stake in shares of Astera Labs during the 4th quarter worth $5,091,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Astera Labs

In related news, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the completion of the transaction, the director directly owned 319,863 shares of the company’s stock, valued at $34,420,457.43. The trade was a 36.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 2,311,256 shares of company stock valued at $477,341,446. 10.40% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Citigroup lowered shares of Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday, May 26th. Rothschild & Co Redburn started coverage on shares of Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective on the stock. UBS Group started coverage on shares of Astera Labs in a research report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective on the stock. Needham & Company LLC boosted their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Finally, Susquehanna boosted their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $233.75.

Astera Labs Price Performance

Astera Labs stock opened at $317.06 on Monday. Astera Labs, Inc. has a 52 week low of $84.78 and a 52 week high of $372.37. The firm’s 50-day simple moving average is $212.95 and its 200 day simple moving average is $171.81. The firm has a market capitalization of $54.35 billion, a PE ratio of 214.23, a P/E/G ratio of 4.20 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same period in the previous year, the firm earned $0.33 EPS. The business’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.